Clinical Trial Update: Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether oral acetazolamide and brimonidine tartrate, with anterior chamber paracentesis, can reduce intraocular pressure after bevacizu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy
• Macular Edema

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)
• BRIMONIDINE TARTRATE (brimonidine tartrate)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Macular Edema, Diabetic Retinopathy | Phase 2 | Status: COMPLETED